PROCHLORPERAZINE MALEATE 5mg. IP

A phenothiazine derivative is used in the treatment of managing schizophrenia, anxiety, vertigo and severe nausea and vomiting. Blocks dopamine receptors in the brain, particularly the D2 receptors that helps regulate mood, behaviours, and thoughts. (Din & Preuss.) A safe and effective option for treating dizziness accompanied by nausea or vomiting in patients with vertiginous disorders. (Bond, 1998) Effectively controls nausea and vomiting induced by chemotherapy, radiation therapy, surgery, or motion sickness. Effectively modulates neurotransmitter signaling, which helps alleviate symptoms like nausea, vomiting, and dizziness associated with vestibular disorders. (M. Ilambarathi, 2024) A safe and reliable option for managing symptoms of nausea, vomiting, dizziness, and other vestibular disturbances. (M. Ilambarathi, 2024) A promising therapeutic agent for managing conditions like vestibular migraine. (M. Ilambarathi, 2024) Reduces the intensity and frequency of acute vertigo episodes associated with diverse etiologies. (Mohan Kameswaran, 2023) A therapeutic option for vertigo patients, including those with postoperative vertigo and vestibular disorders. (Mohan Kameswaran, 2023) Relieves both vestibular symptoms and associated vegetative symptoms of vertigo, including nausea, vomiting, and anxiety. (Mohan Kameswaran, 2023) More effective than betahistine and cinnarizine in preventing the recurrence of vertigo episodes within the first week. (Mohan Kameswaran, 2023)